Disability is common among children born prematurely and is inversely related to gestational age at birth. As many as one half of those surviving after birth at 25 wk gestational age or less have a severe disability at 21/2 years of age, 50% of these being severe (1) . Even those seemingly unaffected early on may demonstrate a range of motor, cognitive, behavioral, psychological, emotional, and educational deficits later in childhood (2) (3) (4) . To date, a series of risk factors for such cognitive impairment (e.g. birth weight, chronic lung disease, and social factors) have been identified, although the biologic transduction mechanisms that result in cerebral injury remain occult (5) .
The pro-inflammatory cytokine IL-6 may be one such biologic mediator. Perinatal concentrations of the pro-inflammatory cytokines such as IL-6 correlate directly with the development of periventricular WMD and subsequent neurologic deficit (6 -10) . WMD, in turn, may impair gray matter development throughout childhood (11, 12) and is perhaps responsible for some of the developmental deficits observed in children after premature birth. Correlating structural brain abnormality with specific functional deficits has proved difficult, however (13) .
It remains unclear as to whether the association of elevated IL-6 levels with cerebral injury is innocent or causal. A genetic strategy of investigation may help elucidate the pathways that cause such injury: the association of a functional variant in the IL-6 gene with impaired neurological outcome would offer substantial evidence of causality. A candidate gene association study of this variety has advantages in the assessment of cytokine pathogenicity, where levels fluctuate rapidly and wildly, where total chronic burden of exposure cannot be measured, and where tissue generation may be more important than circulating levels themselves (14) . Such a genetic variant does exist, which is applicable to such a study: a G/C substitution has been identified at position -572 in the IL-6 gene-the rare C allele being associated with a higher IL-6 synthetic response (14) .
If IL-6 plays a causal role in mediating cerebral injury and cognitive developmental progress after preterm birth, the C allele should be associated with such cognitive impairment. We have performed a pilot study to examine this hypothesis, using a well-defined cohort of preterm infants (15) with structured neurodevelopmental follow-up to 51/2 y of age.
METHODS
Patients and developmental assessment. The study was approved by the ethical committees of Southmead Hospital and United Bristol Health Care Trust. Parental consent was obtained for participation in neurodevelopmental follow-up (15). Consent was not required for the genetic component of this study, as all personal information was held separately from the genetic information and patients were identified solely by study codes. The patients (Յ32 wk gestation, Caucasian) participated in a population-based developmental outcome study, the Avon Premature Infant Project (APIP) (15) . Patients were prospectively recruited to a randomized controlled trial of Portage (an early education programme focused on the child) or social support (parent adviser scheme focused on the mother) intervention started at discharge and continued for up to 2 y, as previously described (15) . Patients who were followed up at 2 and 5.5 y were identified and Guthrie spots located where possible. Genotypes were successfully determined in 113 patients (below), representing 37% of the original APIP population (n ϭ 308) and 60% of all infants followed up to 5.5 y (n ϭ 187).
Cognitive and motor functions were assessed using the Griffiths Developmental Scales at 2 y and British Ability Scales (2nd Ed.) (BAS) and the ABC Movement Score at 51/2 y. The Griffiths Mental Development Scales, used to assess motor and cognitive performance, was performed at 2 y corrected age (16) . The Griffiths scales comprise five subscales, including personal and social, hearing and speech, locomotor, eye hand co-ordination, and performance domains, from which is derived an overall developmental quotient (DQ). A lower Griffiths DQ reflects a poorer neuro-developmental performance. A score of 70 (-2 SD) would indicate severe disability instead of the conventional 55 (-3 SD) due to secular drifts in population scores that have resulted in a higher population mean. Cognitive developmental progress at 5.5 y of age was assessed using the BAS (17) . The BAS computes GCA together with visuospatial, verbal, and nonverbal subscales. The GCA is a developmental quotient equivalent to an IQ estimate, normalized at 100 (SD Ϯ 15) in which a lower score again indicates poorer conceptual ability. The Movement ABC scales (18) assesses manual dexterity, ball skills, and balance over 10 tests. Scores of each component are summed to produce a score ranging from 0 to 40, with high scores indicating more impaired motor skills and scores close to 0 normal skills. A psychologist performed the Griffiths Scales of Mental Development, a second psychologist performed the BAS, and a research nurse the Movement ABC tests. These assessments were blind to the child's neonatal course and progress.
Cranial injury. Cranial ultrasound was performed on the day of birth, and then at least weekly until discharge. Images were reviewed prospectively (N.M.). Hemorrhagic ultrasound findings were classified as subependymal, intraventricular, or intraparenchymal, intraventricular hemorrhage being graded as small or large (the latter where the clot distended the lateral ventricle). Severe hemorrhage was defined as a large intraventricular hemorrhage or an intraparenchymal hemorrhage. Cystic periventricular leukomalacia was defined as echo-lucent cysts of Ն2 mm diameter in the periventricular white matter; ventriculomegaly was present if the ventricular size on the last scan was Ͼ97 th percentile (19) . No children developed progressive posthemorrhagic hydrocephalus in this cohort. For analysis, cystic periventricular leukomalacia and ventriculomegaly were combined as PVL consistent with the view that most ventricular enlargement is due to WMD, either focal (cystic) or diffuse (20 -22) . The worst grade of findings was used in all cases.
Genotyping. DNA was extracted from routinely stored Guthrie cards and IL-6 genotypes determined as previously described (14) using the primers (5'-GGAGACGCCTTG-AAGTAACTGC-3' and 5'-GAGTTTCCTCT-GACTCCATC-GCAG-3') to generate a 163 bp PCR fragment. Genotypes were resolved by using restriction endonuclease digestion. The rare -572 C allele lacks the digestion site for MbI1. The size of the digestion products was determined by using microtiter array diagonal gel electrophoresis by two independent observers blinded to clinical details.
Statistical analysis. Outcomes were examined for association with IL-6 promoter polymorphism genotypes -572 CCϩCG compared with GG, using SPSS for Windows v9.0 (SPSS Inc, Chicago, IL). Categorical data were analysed by chi-square or Fisher's exact test where appropriate. MannWhitney U was used for simple comparison of continuous data; data shown are median (interquartile range). Multiple linear regression was used posthoc to control for potential confounders of outcome measures associated with genotype. A probability of p Ͻ0.05 was considered statistically significant for examination of primary outcomes. Secondary analysis was performed to demonstrate any association between genotype, disability, and performance in subscales of the developmental tests. Adjustment for multiple comparison was made using the Bonferroni correction. A probability of p Ͻ 0.005 was considered statistically significant for secondary (subscale) analysis. Genotype frequencies, CC 1 (1%), GC 9 (8%), GG 103 (91%), demonstrated Hardy-Weinberg equilibrium and were similar to UK population controls, suggesting no survival selection before enrolment (14) . Median gestational age of infants with Ն1 C allele was lower than the comparison group (GG genotype): 29 (27-30) wk gestation and 31 (29 -32) wk, respectively. All other demographic and neonatal variables were similar (Table 1) .
RESULTS

IL
There was no difference in the incidence of cranial ultrasound abnormalities across genotype groups: severe IVH occurred in 0 of the carriers of the C allele and in 7 (7%) of the GG genotype infants (p ϭ 0.91), whereas WMD due to all PVL was observed in 1 (10%) of those with a C allele and 11 (11%) of those of GG genotype (p ϭ 0.99) ( Table 1) . Cystic PVL occurred in 1 (10%) of those with the C allele compared with 4 (4%) in GG infants and ventriculomegaly was found on 0 (0%) and 7 (7%) occasions, respectively. Two (20%) of the infants with a C allele were born at Ͻ27 wk gestation compared with 7 (7%) of those with GG genotype (p ϭ 0.18). Both of the infants Ͻ27 wk carrying a C , 1-10 ). C allele carriage was associated with worse DQ at 2 y and GCA at 51/2y but not worse motor performance (2 y 
DISCUSSION
We have demonstrated an association between IL-6 -572 C allele carriage and worse cognitive development after preterm birth. The numbers of patients carrying the relatively rare -572 C allele was small (10) and further confirmatory studies are clearly required, as are haplotype analyses in larger cohorts (24) .
The lack of association between C allele carriage and ultrasound changes consistent with cystic PVL and ventriculomegaly may be due to the rarity of the C allele and the small number of patients with ultrasonographic evidence of white matter injury. The resolution of cranial ultrasonography is clearly inadequate to define all white matter injury (25) , of which perhaps 50% of very preterm infants suffer to some extent. It is possible, therefore, that the link between the IL-6 -572 C allele and worse developmental performance at 2 and 5.5 y is due to IL-6 -mediated white matter damage affecting subsequent gray matter development and its ongoing wiring into childhood (11) . Certainly, preterm infants with MRI evidence of white matter injury have reduced cortical gray matter volume (12) . The mechanisms that injure the developing gray matter are, however, poorly elucidated and the same mechanisms that injure the white matter may directly affect gray matter. Nothing is known about constitutive IL-6 gene expression or IL-6 gene expression in response to ischemic, infective, or inflammatory signals within different areas of the preterm brain. It is therefore possible that gray matter injury and impaired cognitive development may occur independently of white matter damage and that different responses may be mediated by different IL-6 promoter polymorphisms.
Despite the association between C allele carriage and worse DQ and GCA, we did not demonstrate a statistically significant link between genotype and motor performance in the BAS or in the locomotor subscale of the Griffiths scales. There was, however, a clear trend toward worse overall performance in the ABC movement tests among C allele carriers (p ϭ 0.08), which requires further exploration.
We also found an association between C allele carriage and lower gestational age in this cohort. It is possible that the -572 C allele is a risk factor for preterm birth, as other polymorphisms of pro-inflammatory cytokine and signalling molecules are also associated with preterm delivery (26, 27) . The greater degree of immaturity in those carrying a C allele does not appear to explain fully the impact upon cognitive outcome, however, as gestational age was not predictive of a lower DQ or GCA. Given the small numbers of patients within this cohort studied, the lack of association between gestational age and outcomes could be the result of a type 11 error. Thus, impaired cerebral development, or perhaps more correctly developmental performance, could also (or in addition) be driven by the C allele predisposing to preterm birth. However, the size of any effects of gestational age upon DQ and GCA appear to be small in comparison to that of genotype. Neither did CCϩCG infants have more adverse risk factors than their GG counterparts (Table 1) . Furthermore, none of those infants carrying the -572 C allele had severe IVH. Nor was there any difference in social or parental factors or developmental support (Table 2) , and nor was this association driven by the poor performance of disabled infants carrying a -572 C allele (Table 2) .
We have used a candidate gene association approach to investigate the role of IL-6 in cognitive development after premature birth. These data are consistent with IL-6 expression modulating cognitive development in the preterm infant. It is unlikely that basal IL-6 expression itself is responsible for this effect alone, but is due to the complex interactions of the many pro-inflammatory events to which the brain of a preterm infant is exposed, potentiated by an individual infant's proinflammatory response. This response may in turn be mediated by such polymorphism as the IL-6 -572 G to C substitution. Such environmental stimuli to IL-6 expression may include maternal infection, intrauterine infection, delivery mode, hypoxia, septicemia, and chronic lung disease (6,7,9,10,28 -33) . Because of the small numbers of patients in this preliminary study, use of two-by-four tables to try to dissect the geneenvironment interactions, perhaps the gold standard for large epidemiologic genetic study (34) , is not possible here. Because of the rarity of the C allele, the numbers of infants are necessarily small in this group, however, if robust, such find-119 IL-6 GENOTYPE AND COGNITIVE DEVELOPMENT ings might contribute to risk analysis among preterm infants and suggest a potential role for antiinflammatory strategies in management of the preterm child (35) .
